Disease-specific biomarker discovery by aptamers

Cytometry Part A

Volumn 75, Issue 9, 2009, Pages 727-733

  Ulrich, Henning ^a,c   Wrenger, Carsten ^b  

^a UNIVERSITY OF SÃO PAULO   (Brazil)

^b BERNHARD NOCHT INSTITUTE FOR TROPICAL MEDICINE   (Germany)

^c NONE   (Brazil)

Author keywords

Aptamers; Cell and target protein identification; Deconvolution SELEX; Fluorescence labeled aptamers for clinical and cytomics application; Plasmodium falciparum

Indexed keywords

APTAMER; CELL SURFACE PROTEIN; EPITOPE;

ANTIGEN EXPRESSION; CELL SELECTION; CELL SURFACE; COMBINATORIAL CHEMISTRY; FLOW CYTOMETRY; FLUORESCENCE; HUMAN; LASER MICROSCOPY; MOLECULAR RECOGNITION; NONHUMAN; PLASMODIUM FALCIPARUM; PRIORITY JOURNAL; REVIEW; TRYPANOSOMA;

ANIMALS; APTAMERS, NUCLEOTIDE; BIOLOGICAL MARKERS; DNA, PROTOZOAN; FLOW CYTOMETRY; HUMANS; IMAGE CYTOMETRY; MALARIA, FALCIPARUM; PLASMODIUM FALCIPARUM; RNA, PROTOZOAN; SELEX APTAMER TECHNIQUE; TRYPANOSOMA; TRYPANOSOMIASIS;

EID: 68849108343     PISSN: 15524922     EISSN: 15524930     Source Type: Journal    
DOI: 10.1002/cyto.a.20766     Document Type: Review

References (75)

1. Tuerk C, Gold L. Systematic evolution of ligands by exponential enrichment: RNA ligands to bacteriophage T4 DNA polymerase. Science 1990;249:505-510. (Pubitemid 20248891)
2. Ellington AD, Szostak JW. In vitro selection of RNA molecules that bind specific ligands. Nature 1990;346:818-822.
3. Ulrich H, Trujillo CA, Nery AA, Alves JM, Majumder P, Resende RR, Martins AH. DNA and RNA aptamers: From tools for basic research towards therapeutic applications. Comb Chem High Throughput Screen 2006;9:619-632. (Pubitemid 44320411)
4. Hess GP, Ulrich H, Breitinger HG, Niu L, Gameiro AM, Grewer C, Srivastava S, Ippolito JE, Lee SM, Jayaraman V, Coombs SE. Mechanism-based discovery of ligands that counteract inhibition of the nicotinic acetylcholine receptor by cocaine and MK- 801. Proc Natl Acad Sci USA 2000;97:13895-13900.
5. Faria M, Ulrich H. The use of synthetic oligonucleotides as protein inhibitors and anticode drugs in cancer therapy: Accomplishments and limitations. Curr Cancer Drug Targets 2002;2:355-368. (Pubitemid 35303469)
6. Faria M, Ulrich H. Sugar boost: When ribose modifications improve oligonucleotide performance. Curr Opin Mol Ther 2008;10:168-175.
7. Ulrich H, Martins AH, Pesquero JB. RNA and DNA aptamers in cytomics analysis. Cytometry Part A 2004;59A:220-231.
8. Ng EW, Adamis AP. Anti-VEGF aptamer (pegaptanib) therapy for ocular vascular diseases. Ann N YAcad Sci 2006;1082:151-171.
9. Gilbert JC, DeFeo-Fraulini T, Hutabarat RM, Horvath CJ, Merlino PG, Marsh HN, Healy JM, Boufakhreddine S, Holohan TV, Schaub RG. First-in-human evaluation of anti von Willebrand factor therapeutic aptamer ARC1779 in healthy volunteers. Circulation 2007;116:2678-2686. (Pubitemid 350291240)
10. Rusconi CP, Scardino E, Layzer J, Pitoc GA, Ortel TL, Monroe D, Sullenger BA. RNA aptamers as reversible antagonists of coagulation factor IXa. Nature 2002;419:90-94. (Pubitemid 34987876)
11. Chan MY, Cohen MG, Dyke CK, Myles SK, Aberle LG, Lin M, Walder J, Steinhubl SR, Gilchrist IC, Kleiman NS, Vorchheimer DA, Chronos N, Melloni C, Alexander JH, Harrington RA, Tonkens RM, Becker RC, Rusconi CP. Phase 1b randomized study of antidote-controlled modulation of factor IXa activity in patients with stable coronary artery disease. Circulation 2008;117:2865-2874. (Pubitemid 351787073)
12. Sennino B, Falcon BL, McCauley D, Le T, McCauley T, Kurz JC, Haskell A, Epstein DM, McDonald DM. Sequential loss of tumor vessel pericytes and endothelial cells after inhibition of platelet-derived growth factor B by selective aptamer AX102. Cancer Res 2007;67:7358-7367. (Pubitemid 47206566)
13. Huang J, Moore J, Soffer S, Kim E, Rowe D, Manley CA, O'Toole K, Middlesworth W, Stolar C, Yamashiro DJ, Kandel JJ. Highly specific antiangiogenic therapy is effective in suppressing growth of experimental Wilms tumors. J Pediatr Surg 2001;36:357-361. (Pubitemid 32114136)
14. Ireson CR, Kelland LR. Discovery and development of anticancer aptamers. Mol Cancer Ther 2006;5:2957-2962.
15. Chu TC, Marks JW III, Lavery LA, Faulkner S, Rosenblum MG, Ellington AD, Levy M. Aptamer: Toxin conjugates that specifically target prostate tumor cells. Cancer Res 2006;66:5989-5992.
16. Wullner U, Neef I, Eller A, Kleines M, Tur MK, Barth S. Cell-specific induction of apoptosis by rationally designed bivalent aptamer-siRNA transcripts silencing eukaryotic elongation factor 2. Curr Cancer Drug Targets 2008;8:554-565.
17. Phillips JA, Lopez-Colon D, Zhu Z, Xu Y, Tan W. Applications of aptamers in cancer cell biology. Anal Chim Acta 2008;621:101-108.
18. Tang Z, Parekh P, Turner P, Moyer RW, Tan W. Generating aptamers for recognition of virus-infected cells. Clin Chem 2009;55:813-822.
19. Chen F, Zhou J, Luo F, Mohammed AB, Zhang XL. Aptamer from whole-bacterium SELEX as new therapeutic reagent against virulent Mycobacterium tuberculosis. Biochem Biophys Res Commun 2007;357:743-748. (Pubitemid 46653843)
20. Moreno M, Rincon E, Pineiro D, Fernandez G, Domingo A, Jimenez-Ruiz A, Salinas M, Gonzalez VM. Selection of aptamers against KMP-11 using colloidal gold during the SELEX process. Biochem Biophys Res Commun 2003;308:214-218. (Pubitemid 36937168)
21. Ulrich H, Magdesian MH, Alves MJ, Colli W. In vitro selection of RNA aptamers that bind to cell adhesion receptors of Trypanosoma cruzi and inhibit cell invasion. J Biol Chem 2002;277:20756-20762.
22. Homann M, Goringer HU. Combinatorial selection of high affinity RNA ligands to live African trypanosomes. Nucleic Acids Res 1999;27:2006-2014. (Pubitemid 29209561)
23. Raddatz MS, Dolf A, Endl E, Knolle P, Famulok M, Mayer G. Enrichment of celltargeting and population-specific aptamers by fluorescence-activated cell sorting. Angew Chem Int Ed Engl 2008;47:5190-5193.
24. Shangguan D, Li Y, Tang Z, Cao ZC, Chen HW, Mallikaratchy P, Sefah K, Yang CJ, Tan W. Aptamers evolved from live cells as effective molecular probes for cancer study. Proc Natl Acad Sci USA 2006;103:11838-11843. (Pubitemid 44215773)
25. Herr JK, Smith JE, Medley CD, Shangguan D, Tan W. Aptamer-conjugated nanoparticles for selective collection and detection of cancer cells. Anal Chem 2006;78:2918-2924. (Pubitemid 43726108)
26. Morris KN, Jensen KB, Julin CM, Weil M, Gold L. High affinity ligands from in vitro selection: Complex targets. Proc Natl Acad Sci USA 1998;95:2902-2907. (Pubitemid 28135827)
27. Ulrich H, Ippolito JE, Pagan OR, Eterovic VA, Hann RM, Shi H, Lis JT, Eldefrawi ME, Hess GP. In vitro selection of RNA molecules that displace cocaine from the membranebound nicotinic acetylcholine receptor. Proc Natl Acad Sci USA 1998; 95:14051-14056.
28. Guo KT, Schäfer R, Paul A, Gerber A, Ziemer G, Wendel HP. A new technique for the isolation and surface immobilization of mesenchymal stem cells from whole bone marrow using high-specific DNA aptamers. Stem Cells 2006;24:2220-2231. (Pubitemid 44527475)
29. Daniels DA, Chen H, Hicke BJ, Swiderek KM, Gold L. A tenascin-C aptamer identified by tumor cell SELEX: Systematic evolution of ligands by exponential enrichment. Proc Natl Acad Sci USA 2003;100:15416-15421. (Pubitemid 38021004)
30. Bruno JG, Kiel JL. In vitro selection of DNA aptamers to anthrax spores with electrochemiluminescence detection. Biosens Bioelectron 1999;14:457-464.
31. Golden MC, Collins BD, Willis MC, Koch TH. Diagnostic potential of PhotoSELEXevolved ssDNA aptamers. J Biotechnol 2000;81:167-178.
32. Golden MC, Resing KA, Collins BD, Willis MC, Koch TH. Mass spectral characterization of a protein-nucleic acid photocrosslink. Protein Sci 1999;8:2806-2812.
33. Jayasena SD. Aptamers: An emerging class of molecules that rival antibodies in diagnostics. Clin Chem 1999;45:1628-1650.
34. Ruckman J, Green LS, Beeson J, Waugh S, Gillette WL, Henninger DD, Claesson- Welsh L, Janjic N. 2'-Fluoropyrimidine RNA-based aptamers to the 165-amino acid form of vascular endothelial growth factor (VEGF165). Inhibition of receptor binding and VEGF-induced vascular permeability through interactions requiring the exon 7-encoded domain. J Biol Chem 1998;273:20556-20567. (Pubitemid 28377626)
35. Meisenheimer KM, Meisenheimer PL, Willis MC, Koch TH. High yield photocrosslinking of a 5-iodocytidine (IC) substituted RNA to its associated protein. Nucleic Acids Res 1996;24:981-982.
36. Willis MC, Hicke BJ, Uhlenbeck OC, Cech TR, Koch TH. Photocrosslinking of 5-iodouracil-substituted RNA and DNA to proteins. Science 1993;262:1255-1257. (Pubitemid 24036089)
37. Hamaguchi N, Ellington A, Stanton M. Aptamer beacons for the direct detection of proteins. Anal Biochem 2001;294:126-131. (Pubitemid 32641757)
38. Yamamoto R, Baba T, Kumar PK. Molecular beacon aptamer fluoresces in the presence of Tat protein of HIV-1. Genes Cells 2000;5:389-396. (Pubitemid 30409094)
39. Goodale D, Phay C, Postenka CO, Keeney M, Allan AL. Characterization of tumor cell dissemination patterns in preclinical models of cancer metastasis using flow cytometry and laser scanning cytometry. Cytometry Part A 2009;75A:344-355.
40. Kiss E, Nagy P, Balogh A, Szöllosi J, Matkó J. Cytometry of raft and caveola membrane microdomains: From flow and imaging techniques to high throughput screening assays. Cytometry Part A 2008;73A:599-614. (Pubitemid 351930747)
41. Wessels JT, Busse AC, Mahrt J, Dullin C, Grabbe E, Mueller GA. In vivo imaging in experimental preclinical tumor research-A review. Cytometry Part A 2007;71A:542-549.
42. Davis KA, Abrams B, Lin Y, Jayasena SD. Use of a high affinity DNA ligand in flow cytometry. Nucleic Acids Res 1996;24:702-706. (Pubitemid 26085845)
43. Davis KA, Lin Y, Abrams B, Jayasena SD. Staining of cell surface human CD4 with 2'- F-pyrimidine-containing RNA aptamers for flow cytometry. Nucleic Acids Res 1998;26:3915-3924. (Pubitemid 28401340)
44. Blank M, Weinschenk T, Priemer M, Schluesener H. Systematic evolution of a DNA aptamer binding to rat brain tumor microvessels. Selective targeting of endothelial regulatory protein pigpen. J Biol Chem 2001;276:16464-16468. (Pubitemid 37391695)
45. Li N, Ebright JN, Stovall GM, Chen X, Nguyen HH, Singh A, Syrett A, Ellington AD. Technical and biological issues relevant to cell typing with aptamers. J Proteome Res 2009;8:2438-2448.
46. Homann M, Göringer HU. Uptake and intracellular transport of RNA aptamers in African trypanosomes suggest therapeutic "piggy-back" approach. Bioorg Med Chem 2001;9:2571-2580.
47. Li W, Yang X, Wang K, Tan W, He Y, Guo Q, Tang H, Liu J. Real-time imaging of protein internalization using aptamer conjugates. Anal Chem 2008;80:5002-5008. (Pubitemid 351956308)
48. Hicke BJ, Stephens AW, Gould T, Chang YF, Lynott CK, Heil J, Borkowski S, Hilger CS, Cook G, Warren S, Schmidt PG. Tumor targeting by an aptamer. J Nucl Med 2006;47:668-678.
49. Ko MH, Kim S, Kang WJ, Lee JH, Kang H, Moon SH, Hwang DW, Ko HY, Lee DS. In vitro derby imaging of cancer biomarkers using quantum dots. Small 2009;5:1207-1212.
50. Huang YF, Chang HT, Tan W. Cancer cell targeting using multiple aptamers conjugated on nanorods. Anal Chem 2008;80:567-572. (Pubitemid 351206842)
51. Bagalkot V, Zhang L, Levy-Nissenbaum E, Jon S, Kantoff PW, Langer R, Farokhzad OC. Quantum dot-aptamer conjugates for synchronous cancer imaging, therapy, and sensing of drug delivery based on bi-fluorescence resonance energy transfer. Nano Lett 2007;7:3065-3070. (Pubitemid 350132931)
52. Li S, Xu H, Ding H, Huang Y, Cao X, Yang G, Li J, Xie Z, Meng Y, Li X, Zhao Q, Shen B, Shao N. Identification of an aptamer targeting hnRNP A1 by tissue slide-based SELEX. J Pathol 2009;218:327-336.
53. Chen Y, Munteanu AC, Huang YF, Phillips J, Zhu Z, Mavros M, Tan W. Mapping receptor density on live cells by using fluorescence correlation spectroscopy. Chemistry 2009;15:5327-5336.
54. Ouaissi MA, Afchain D, Capron A, Grimaud JA. Fibronectin receptors on Trypanosoma cruzi trypomastigotes and their biological function. Nature 1984;308:380-382. (Pubitemid 14136676)
55. Giordano R, Fouts DL, Tewari D, Colli W, Manning JE, Alves MJ. Cloning of a surface membrane glycoprotein specific for the infective form of Trypanosoma cruzi having adhesive properties to laminin. J Biol Chem 1999;274:3461-3468. (Pubitemid 29077186)
56. Herrera EM, Ming M, Ortega-Barria E, Pereira ME. Mediation of Trypanosoma cruzi invasion by heparan sulfate receptors on host cells and penetrin counter-receptors on the trypanosomes. Mol Biochem Parasitol 1994;65:73-83. (Pubitemid 24232817)
57. Homann M, Lorger M, Engstler M, Zacharias M, Goringer HU. Serum-stable RNA aptamers to an invariant surface domain of live African trypanosomes. Comb Chem High Throughput Screen 2006;9:491-499. (Pubitemid 44156707)
58. Lorger M, Engstler M, Homann M, Goringer HU. Targeting the variable surface of African trypanosomes with variant surface glycoprotein-specific, serum-stable RNA aptamers. Eukaryot Cell 2003;2:84-94. (Pubitemid 36770378)
59. Crabb BS, Triglia T, Waterkeyn JG, Cowman AF. Stable transgene expression in Plasmodium falciparum. Mol Biochem Parasitol 1997;90:131-144. (Pubitemid 28044383)
60. Duraisingh MT, Triglia T, Cowman AF. Negative selection of Plasmodium falciparum reveals targeted gene deletion by double crossover recombination. Int J Parasitol 2002;32:81-89. (Pubitemid 34131595)
61. Maier AG, Rug M, O'Neill MT, Brown M, Chakravorty S, Szestak T, Chesson J, Wu Y, Hughes K, Coppel RL, et al. Exported proteins required for virulence and rigidity of Plasmodium falciparum-infected human erythrocytes. Cell 2008;134:48-61. (Pubitemid 351905737)
62. Gunther S, Wallace L, Patzewitz EM, McMillan PJ, Storm J, Wrenger C, Bissett R, Smith TK, Muller S. Apicoplast lipoic acid protein ligase B is not essential for Plasmodium falciparum. PLoS Pathog 2007;3:e189.
63. Waller KL, Cooke BM, NunomuraW, Mohandas N, Coppel RL. Mapping the binding domains involved in the interaction between the Plasmodium falciparum knob-associated histidine-rich protein (KAHRP) and the cytoadherence ligand P. falciparum erythrocyte membrane protein 1 (PfEMP1). J Biol Chem 1999;274:23808-23813. (Pubitemid 129528417)
64. Foth BJ, Ralph SA, Tonkin CJ, Struck NS, Fraunholz M, Roos DS, Cowman AF, McFadden GI. Dissecting apicoplast targeting in the malaria parasite Plasmodium falciparum. Science 2003;299:705-708. (Pubitemid 36159484)
65. Wrenger C, Muller S. The human malaria parasite Plasmodium falciparum has distinct organelle-specific lipoylation pathways. Mol Microbiol 2004;53:103-113. (Pubitemid 38901383)
66. Marti M, Good RT, Rug M, Knuepfer E, Cowman AF. Targeting malaria virulence and remodeling proteins to the host erythrocyte. Science 2004;306:1930-1933. (Pubitemid 39627856)
67. Perkins ME. Surface proteins of Plasmodium falciparum merozoites binding to the erythrocyte receptor, glycophorin. J Exp Med 1984;160:788-798.
68. Gardner MJ, Hall N, Fung E, White O, Berriman M, Hyman RW, Carlton JM, Pain A, Nelson KE, Bowman S, et al. Genome sequence of the human malaria parasite Plasmodium falciparum. Nature 2002;419:498-511.
69. Hiller NL, Bhattacharjee S, van Ooij C, Liolios K, Harrison T, Lopez-Estrano C, Haldar K. A host-targeting signal in virulence proteins reveals a secretome in malarial infection. Science 2004;306:1934-1937. (Pubitemid 39627857)
70. Sargeant TJ, Marti M, Caler E, Carlton JM, Simpson K, Speed TP, Cowman AF. Lineage- specific expansion of proteins exported to erythrocytes in malaria parasites. Genome Biol 2006;7:R12. (Pubitemid 43871858)
71. Lingelbach K, Przyborski JM. The long and winding road: Protein trafficking mechanisms in the Plasmodium falciparum infected erythrocyte. Mol Biochem Parasitol 2006;147:1-8.
72. Ravindran S, Boothroyd JC. Secretion of proteins into host cells by Apicomplexan parasites. Traffic 2008;9:647-656.
73. Smith RA, Giorgio TD. Quantitative measurement of multifunctional quantum dot binding to cellular targets using flow cytometry. Cytometry Part A 2009;75A:465-474.
74. Wang L, Gaigalas AK, Marti G, Abbasi F, Hoffman RA. Toward quantitative fluorescence measurements with multicolor flow cytometry. Cytometry Part A 2008;73A:279-788.
75. Muller IB, Wu F, Bergmann B, Knockel J, Walter RD, Gehring H, Wrenger C. Poisoning pyridoxal 5-phosphate-dependent enzymes: A new strategy to target the malaria parasite Plasmodium falciparum. PLoS One 2009;4:e4406.